Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Facebook groups aim to boost skin checks in young melanoma families

NCT ID NCT03677739

Knowledge-focused Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at whether Facebook groups can help young people diagnosed with melanoma (ages 18-39) and their close relatives do more skin exams and sun protection. About 1,160 participants will join either a melanoma-focused Facebook group or a healthy lifestyle Facebook group. The goal is to see if social media can improve skin check habits and catch new melanomas early.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Facebook-based informational intervention
What this could lead to
If it works, this could show that social media is a useful tool to encourage skin checks and sun safety in families affected by melanoma.
What could go wrong
This is not testing a drug or treatment—it's a behavioral study. Results may not apply to everyone, and people might not change their habits just from Facebook posts.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2019

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * PATIENT: Diagnosed with stage 0-3 melanoma in the last 5 years * PATIENT: Age at diagnosis 18-39 years * PATIENT: Completed treatment at least 3 months previously * PATIENT: Recruited from New Jersey or California State Cancer Registry or MD Anderson Cancer Center * PATIENT: Does not have a concurrent cancer diagnosis * PATIENT: Able to speak and read English * PATIENT: Access to computer, internet, and has a Facebook account * PATIENT: At least one family member consents * FDR: Current age 18-80 years * FDR: Does not have a personal history of melanoma * FDR: Able to speak and read English * FDR: Access to computer, internet, and has a Facebook account * FDR: Has only one FDR with melanoma (patient) * FDR: Has not had a total cutaneous examination (TCE) in the past 3 years, has done skin self-exam (SSE) fewer than three times in the past year, OR has a sun protection habits average score less than or equal to 4 (?often?) * FDR: Patient consents Exclusion Criteria: * Physical Activity Readiness Questionnaire (Thomas, et. al., 1992): This 7-item scale will be used to screen out individuals who will need to consult a physician for medical clearance before engaging in physical activity. If a participant checks off any of the items, the investigators will ask for a physician clearance before consenting to study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Clinical stage 0 cutaneous melanoma ajcc V8 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cutaneous melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Clinical stage 0 cutaneous melanoma ajcc V8 Clinical stage I cutaneous melanoma ajcc V8 Clinical stage IA cutaneous melanoma ajcc V8 Clinical stage IB cutaneous melanoma ajcc V8 Clinical stage II cutaneous melanoma ajcc V8 Clinical stage IIA cutaneous melanoma ajcc V8 Clinical stage IIB cutaneous melanoma ajcc V8 Clinical stage IIC cutaneous melanoma ajcc V8 Clinical stage III cutaneous melanoma ajcc V8 First degree relative Pathologic stage 0 cutaneous melanoma ajcc V8 Pathologic stage I cutaneous melanoma ajcc V8 Pathologic stage IA cutaneous melanoma ajcc V8 Pathologic stage IB cutaneous melanoma ajcc V8 Pathologic stage II cutaneous melanoma ajcc V8 Pathologic stage IIA cutaneous melanoma ajcc V8 Pathologic stage IIB cutaneous melanoma ajcc V8 Pathologic stage IIC cutaneous melanoma ajcc V8 Pathologic stage III cutaneous melanoma ajcc V8 Pathologic stage IIIA cutaneous melanoma ajcc V8 Pathologic stage IIIB cutaneous melanoma ajcc V8 Pathologic stage IIIC cutaneous melanoma ajcc V8

Contacts and locations

Locations

  • MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, 08903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.